These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 34850005)

  • 1. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.
    Jarosinski MA; Chen YS; Varas N; Dhayalan B; Chatterjee D; Weiss MA
    J Clin Endocrinol Metab; 2022 Mar; 107(4):909-928. PubMed ID: 34850005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
    Goldman J; Kapitza C; Pettus J; Heise T
    Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural principles of insulin formulation and analog design: A century of innovation.
    Jarosinski MA; Dhayalan B; Chen YS; Chatterjee D; Varas N; Weiss MA
    Mol Metab; 2021 Oct; 52():101325. PubMed ID: 34428558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.
    Muchmore DB; Vaughn DE
    J Diabetes Sci Technol; 2010 Mar; 4(2):419-28. PubMed ID: 20307403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes.
    Hompesch M; Patel DK; LaSalle JR; Bolli GB
    Postgrad Med; 2019 Mar; 131(2):117-128. PubMed ID: 30691343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Therapy: Future Perspectives.
    Cernea S; Raz I
    Am J Ther; 2020; 27(1):e121-e132. PubMed ID: 31567147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin therapy-new insulin analogues].
    Ehren M; Klein HH
    Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic Human Insulin and Insulin Analogs.
    Rodbard HW; Rodbard D
    Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of non-standard insulin analogs for the treatment of diabetes mellitus.
    Pandyarajan V; Weiss MA
    Curr Diab Rep; 2012 Dec; 12(6):697-704. PubMed ID: 22983891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.
    Rosenstock J; Juneja R; Beals JM; Moyers JS; Ilag L; McCrimmon RJ
    Endocr Rev; 2024 May; 45(3):379-413. PubMed ID: 38224978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
    Ulrich H; Snyder B; Garg SK
    Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of biosynthetic human insulin and its analogues for diabetes management.
    Francis D; Chacko AM; Anoop A; Nadimuthu S; Venugopal V
    Adv Protein Chem Struct Biol; 2024; 142():191-256. PubMed ID: 39059986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Basal Insulins: a Clinical Perspective of Their Use in the Treatment of Type 2 Diabetes and Novel Treatment Options Beyond Basal Insulin.
    Frias PF; Frias JP
    Curr Diab Rep; 2017 Aug; 17(10):91. PubMed ID: 28822051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
    Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
    Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
    DeWitt DE; Dugdale DC
    JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.